Rare diseases
Investigational molecules
Locations
A study of ACR-368 and gemcitabine for patients with endometrial cancer
ItalyA study of ABBV-706 and atezolizumab for patients with previously untreated extensive stage small cell lung cancer
ItalyA study to compare glofitamab against a drug combination for patients with relapsed or refractory mantle cell lymphoma
ItalyA study to evaluate the effectiveness of R2R01 in preventing acute kidney injury in patients at high risk following heart surgery.
ItalyA study to evaluate the safety of ADX-038 in patients with complement-mediated kidney disease
ItalyA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
ItalyA study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer
ItalyA study of DS-3790A, rituximab, and epcoritamab in patients with blood cancers
ItalyA study to evaluate the effectiveness of pirtobrutinib in elderly and frail patients with mantle cell lymphoma who have not yet received treatment.
ItalyStudy of Revumenib, Cytarabine, and Fludarabine in Children with Relapsed or Refractory Acute Myeloid Leukemia
ItalyStudy of ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes
ItalyA study to evaluate the safety and effectiveness of tafasitamab in adults with autoimmune thrombocytopenia or autoimmune hemolytic anemia
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
